Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.
D000208:Acute Disease; D016572:Cyclosporine / Q000008:administration & dosage; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000401:mortality / Q000502:physiology; D020123:Sirolimus / Q000009:adverse effects / Q000627:therapeutic use*; D015996:Survival Rate; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus